Stimulating microglial cells could delay the onset of some neurodegenerative diseases, researchers report.
Researchers from Cardiff University have identified two new genes that can influence a person's risk of developing Alzheimer's disease.
A new study from researchers at WUSTL reveals the TREM2 gene can have both positive and negative implications for the development of Alzheimer's disease and neuroinflammation.
A new paper explores different findings about the development of Alzheimer's and considers how personalized treatments may help combat this complex disease.
A new study reveals head impact, not concussion, triggers CTE. The discovery could help with early detection and treatments for the neurodegenerative disorder.
Researchers report activating microglia may help reduce the imbalance between neuroprotection and neurotoxicity for neurodegenerative diseases.
Researchers report therapeutic activation of the TREM2 gene during the early stages of Alzheimer's disease may help to counteract the formation of amyloid beta protein aggregates.
Two rare genetic variants on the NOTCH3 and TREM2 genes have been identified in some Alzheimer's patients.
Changes in gene expression help researchers identify ALS associated pathways and establish the key drivers of motor neuron degeneration in the disease.
Study in mice and humans reveals reinforcing the activity of microglia could slow, or potentially halt, the proliferation of Tau tangles in Alzheimer's disease.
Findings could help in the development of treatments to prevent brain inflammation associated with Alzheimer's disease.
Stimulating activation of microglia may help eliminate Alzheimer's associated plaques, thus helping to prevent the progression of the neurodegenerative disease.
